lobbying_activities: 2681209
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2681209 | 8f8b7488-7287-43e8-a879-b7a9d2287f51 | Q3 | TODD STRATEGY GROUP | 401103321 | NOVARTIS, INC. | 2021 | third_quarter | PHA | Drug Pricing. Supply Chain. 340B Issues. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2021-10-15T10:40:25.810000-04:00 |